The translational landscape of mTOR signalling steers cancer initiation and metastasis

Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling

Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853

Integrative Genomic Profiling of Human Prostate Cancer

Taylor, B. S., Schultz, N. D., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E. G., Reva, B. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,713

mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery

Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051

Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton

Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665

Regulation of translation initiation by FRAP/mTOR

Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun‐Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C. R., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,410

SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity

Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,407

MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation

Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384

Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,111

Translation control of the immune checkpoint in cancer and its therapeutic targeting

Xu, Y., Poggio, M., Jin, H. Y., Shi, Z., Forester, C. M., Wang, Y., Stumpf, C. R., Xue, L., Devericks, E., So, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0321-2 · Cited by 261

Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer

Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260

Variant ribosomal RNA alleles are conserved and exhibit tissue-specific expression

Parks, M. M., Kurylo, C. M., Dass, R. A., Bojmar, L., Lyden, D., Vincent, C. T., & Blanchard, S. C. (2018) · Science Advances · doi:10.1126/sciadv.aao0665 · Cited by 260

Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3

Robichaud, N., Rincon, S. V. D., Huor, B., Alain, T., Petruccelli, L. A., Hearnden, J., Gonçalves, C., Grotegut, S., Spruck, C., Furic, L., et al. (2014) · Oncogene · doi:10.1038/onc.2014.146 · Cited by 259

Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translationPreprint

Tcherkezian, J., Cargnello, M., Roméo, Y., Huttlin, E. L., Lavoie, G., Gygi, S. P., & Roux, P. P. (2014) · Genes & Development · doi:10.1101/gad.231407.113 · Cited by 272

Role of the PI3K/AKT (mTOR and GSK3β) signalling pathway and photobiomodulation in diabetic wound healing

Jere, S. W., Houreld, N. N., & Abrahamse, H. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.03.001 · Cited by 257

The Role of Target of Rapamycin Signaling Networks in Plant Growth and Metabolism

Xiong, Y., & Sheen, J. (2014) · PLANT PHYSIOLOGY · doi:10.1104/pp.113.229948 · Cited by 258

Translational reprogramming in cellular stress response

Liu, B., & Qian, S. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1212 · Cited by 262

GWIPS-viz: development of a ribo-seq genome browser

Michel, A. M., Fox, G., Kiran, A. M., Bo, C. D., O’Connor, P. B. F., Heaphy, S. M., Mullan, J. P. A., Donohue, C. A., Higgins, D. G., & Baranov, P. V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1035 · Cited by 252

m6A Facilitates eIF4F-Independent mRNA Translation

Coots, R. A., Liu, X., Mao, Y., Dong, L., Zhou, J. L., Wan, J., Zhang, X., & Qian, S. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.10.002 · Cited by 256

mTORC1 signaling controls multiple steps in ribosome biogenesis

Iadevaia, V., Liu, R., & Proud, C. G. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.08.004 · Cited by 248

Proximity RNA Labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

Padrón, A., Iwasaki, S., & Ingolia, N. T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.030 · Cited by 257

Translational control of immune responses: from transcripts to translatomes

Piccirillo, C. A., Bjur, E., Topisirović, I., Sonenberg, N., & Larsson, O. S. (2014) · Nature Immunology · doi:10.1038/ni.2891 · Cited by 250

Quantitative profiling of initiating ribosomes in vivo

Gao, X., Wan, J., Liu, B., Ma, M., Shen, B., & Qian, S. (2014) · Nature Methods · doi:10.1038/nmeth.3208 · Cited by 244

Genome-wide assessment of differential translations with ribosome profiling data

Xiao, Z., Zou, Q., Liu, Y., & Yang, X. (2016) · Nature Communications · doi:10.1038/ncomms11194 · Cited by 236

Quantitative proteomics identifies redox switches for global translation modulation by mitochondrially produced reactive oxygen species

Topf, U., Suppanz, I., Samluk, Ł., Wróbel, L., Böser, A., Sakowska, P., Knapp, B. L., Pietrzyk, M. K., Chacińska, A., & Warscheid, B. (2018) · Nature Communications · doi:10.1038/s41467-017-02694-8 · Cited by 246

Proteome complexity and the forces that drive proteome imbalance

Harper, J. W., & Bennett, E. J. (2016) · Nature · doi:10.1038/nature19947 · Cited by 239

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

Dey, N., De, P. K., & Leyland-Jones, B. R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.037 · Cited by 237

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Hassan, B., Akçakanat, A., Holder, A. M., & Meric‐Bernstam, F. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.008 · Cited by 230

The race to decipher the top secrets of TOP mRNAs

Meyuhas, O., & Kahan, T. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.015 · Cited by 238

Heterogeneity and specialized functions of translation machinery: from genes to organisms

Genuth, N. R., & Barna, M. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0008-z · Cited by 235

Signalling to eIF4E in cancer

Siddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 225

Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition

Katsuno, Y., Meyer, D. S., Zhang, Z., Shokat, K. M., Akhurst, R. J., Miyazono, K., & Derynck, R. (2019) · Science Signaling · doi:10.1126/scisignal.aau8544 · Cited by 219

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer

Pungsrinont, T., Kallenbach, J., & Baniahmad, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011088 · Cited by 218

Translational Control under Stress: Reshaping the Translatome

Advani, V. M., & Ivanov, P. V. (2019) · BioEssays · doi:10.1002/bies.201900009 · Cited by 226

Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis

Buszczak, M., Signer, R. A. J., & Morrison, S. J. (2014) · Cell · doi:10.1016/j.cell.2014.09.016 · Cited by 224

Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth

Melnik, B. C., John, S. M., & Schmitz, G. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-103 · Cited by 213

The Translational Landscape of the Mammalian Cell Cycle

Stumpf, C. R., Moreno, M. V., Olshen, A. B., Taylor, B. S., & Ruggero, D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.018 · Cited by 214

The Translational Regulation in mTOR Pathway

Yang, M., Lu, Y., Piao, W., & Jin, H. (2022) · Biomolecules · doi:10.3390/biom12060802 · Cited by 217

Advances in the treatment of advanced oestrogen-receptor-positive breast cancer

Turner, N. C., Neven, P., Loibl, S., & Andre, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32419-9 · Cited by 205

Translating the genome in time and space: Specialized ribosomes, RNA regulons, and RNA-binding proteins

Shi, Z., & Barna, M. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125346 · Cited by 205

YB-1: oncoprotein, prognostic marker and therapeutic target?

Lasham, A., Print, C. G., Woolley, A. G., Dunn, S. E., & Braithwaite, A. W. (2012) · Biochemical Journal · doi:10.1042/bj20121323 · Cited by 206

Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis

Yue, M., Jiang, J., Gao, P., Liu, H., & Qing, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.002 · Cited by 201

Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation

Rubio, C. A., Weisburd, B., Holderfield, M., Arias, C., Fang, E., DeRisi, J. L., & Fanidi, A. (2014) · Genome Biology · doi:10.1186/s13059-014-0476-1 · Cited by 200

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale

Gandin, V., Sikström, K., Alain, T., Morita, M., McLaughlan, S., Larsson, O. S., & Topisirović, I. (2014) · Journal of Visualized Experiments · doi:10.3791/51455 · Cited by 207

Translational control of stem cell function

Saba, J. A., Liakath‐Ali, K., Green, R., & Watt, F. M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00386-2 · Cited by 205

nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAsPreprint

Gandin, V., Masvidal, L., Hulea, L., Gravel, S., Cargnello, M., McLaughlan, S., Cai, Y., Balanathan, P., Morita, M., Rajakumar, A., et al. (2016) · Genome Research · doi:10.1101/gr.197566.115 · Cited by 204

Distinct perturbation of the translatome by the antidiabetic drug metformin

Larsson, O. S., Morita, M., Topisirović, I., Alain, T., Blouin, M., Pollak, M., & Sonenberg, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201689109 · Cited by 205

LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs

Hong, S., Freeberg, M., Han, T., Kamath, A., Yao, Y., Fukuda, T., Suzuki, T., Kim, J. K., & Inoki, K. (2017) · eLife · doi:10.7554/elife.25237 · Cited by 208

Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle

Melnik, B. C. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.006 · Cited by 204

Programmed cell death‐1 (PD‐1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell–intrinsic PD‐1

Li, H., Li, X., Liu, S., Guo, L., Zhang, B., Zhang, J., & Ye, Q. (2017) · Hepatology · doi:10.1002/hep.29360 · Cited by 197

mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions

Showkat, M., Beigh, M. A., & Andrabi, K. I. (2014) · Molecular Biology International · doi:10.1155/2014/686984 · Cited by 196

Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance

Levitzki, A. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140341 · Cited by 190

mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis

Villa, E., Sahu, U., O’Hara, B. P., Ali, E. S., Helmin, K. A., Asara, J. M., Gao, P., Singer, B. D., & Ben‐Sahra, I. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.009 · Cited by 194

A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma

Fan, Q., Aksoy, O., Wong, R. A., Ilkhanizadeh, S., Novotny, C. J., Gustafson, W. C., Truong, A. Y.-Q., Cayanan, G., Simonds, E. F., Haas-Kogan, D., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.014 · Cited by 180

Translational Control through Differential Ribosome Pausing during Amino Acid Limitation in Mammalian Cells

Darnell, A. M., Subramaniam, A. R., & O’Shea, E. K. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.041 · Cited by 195

AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia

Zhou, F., Liu, Y., Rohde, C., Pauli, C., Gerloff, D., Köhn, M., Misiak, D., Bäumer, N., Cui, C., Göllner, S., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3563 · Cited by 188

La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

Lahr, R. M., Fonseca, B. D., Ciotti, G. E., Al-Ashtal, H. A., Jia, J.-J., Niklaus, M., Blagden, S. P., Alain, T., & Berman, A. J. (2017) · eLife · doi:10.7554/elife.24146 · Cited by 199

On-Site Ribosome Remodeling by Locally Synthesized Ribosomal Proteins in Axons

Shigeoka, T., Koppers, M., Wong, H. H., Lin, J. Q., Cagnetta, R., Dwivedy, A., Nascimento, J. D. F., van Tartwijk, F. W., Ströhl, F., Cioni, J.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.025 · Cited by 192

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

Khanna, C., Fan, T. M., Gorlick, R., Helman, L. J., Kleinerman, E. S., Adamson, P. C., Houghton, P. J., Tap, W. D., Welch, D. R., Steeg, P. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2574 · Cited by 178

A growing role for mTOR in promoting anabolic metabolism

Howell, J. J., Ricoult, S. J. H., Ben‐Sahra, I., & Manning, B. D. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130041 · Cited by 185

Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development

Wang, Q., Tiffen, J. C., Bailey, C. G., Lehman, M., Ritchie, W., Fazli, L., Metierre, C., Feng, Y., Li, E., Gleave, M. E., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt241 · Cited by 175

Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells

Stoyanova, T., Cooper, A. R., Drake, J., Liu, X., Armstrong, A., Pienta, K., Zhang, H., Kohn, D., Huang, J.-T., Witte, O., et al. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1320565110 · Cited by 170

How Ribosomes Translate Cancer

Sulima, S. O., Hofman, I. J., Keersmaecker, K. D., & Dinman, J. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0550 · Cited by 185

Protein synthesis and quality control in aging

Anisimova, A. S., Alexandrov, A. I., Makarova, N. E., Gladyshev, V. N., & Dmitriev, S. E. (2018) · Aging · doi:10.18632/aging.101721 · Cited by 172

PI3K/Akt/mTOR signaling pathway in cancer stem cells

Fath, M. K., Ebrahimi, M., Nourbakhsh, E., Hazara, A. Z., Mirzaei, A., Shafieyari, S., Salehi, A., Hoseinzadeh, M., Payandeh, Z., & Barati, G. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154010 · Cited by 173

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells

Mao, Y., van Hoef, V., Zhang, X., Wennerberg, E., Lorent, J., Witt, K., Masvidal, L., Liang, S., Murray, S. M., Larsson, O. S., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698027 · Cited by 182

RiboDiff: detecting changes of mRNA translation efficiency from ribosome footprints

田中, 義., Karaletsos, T., Drewe, P., Sreedharan, V. T., Kuo, D. C., Singh, K., Wendel, H., & Rätsch, G. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw585 · Cited by 176

De novo annotation and characterization of the translatome with ribosome profiling data

Xiao, Z., Huang, R., Xing, X., Chen, Y., Deng, H., & Yang, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky179 · Cited by 175

Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity

Feoktistova, K., Tuvshintogs, E., Do, A., & Fraser, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303781110 · Cited by 177

Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis

Musa, J., Orth, M. F., Dallmayer, M., Baldauf, M. C., Pardo, C., Rotblat, B., Kirchner, T., Leprivier, G., & Grünewald, T. G. P. (2016) · Oncogene · doi:10.1038/onc.2015.515 · Cited by 175

The expanding role of mTOR in cancer cell growth and proliferation

Cargnello, M., Tcherkezian, J., & Roux, P. P. (2015) · Mutagenesis · doi:10.1093/mutage/geu045 · Cited by 172

Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes

Chen, J., Torcia, S., Xie, F., Lin, C.-J., Çakmak, H., Franciosi, F., Horner, K., Onodera, C. S., Song, J. S., Cedars, M. I., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2873 · Cited by 167

Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation

Liu, X., Zhang, Y., Ni, M., Cao, H., Signer, R. A. J., Li, D., Li, M., Gu, Z., Hu, Z., Dickerson, K. E., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3527 · Cited by 173

The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling

Ricciardi, S., Manfrini, N., Alfieri, R. R., Calamita, P., Crosti, M., Gallo, S., Müller, R., Pagani, M., Abrignani, S., & Biffo, S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.009 · Cited by 172

RNA G-quadruplexes at upstream open reading frames cause DHX36- and DHX9-dependent translation of human mRNAs

Murat, P., Marsico, G., Herdy, B., Ghanbarian, A. T., Portella, G., & Balasubramanian, S. (2018) · Genome biology · doi:10.1186/s13059-018-1602-2 · Cited by 170

Translation is actively regulated during the differentiation of CD8+ effector T cells

Araki, K., Morita, M., Bederman, A., Konieczny, B. T., Kissick, H. T., Sonenberg, N., & Ahmed, R. (2017) · Nature Immunology · doi:10.1038/ni.3795 · Cited by 166

Development of a stress response therapy targeting aggressive prostate cancer

Nguyen, H. G., Conn, C. S., Kye, Y., Xue, L., Forester, C. M., Cowan, J. E., Hsieh, A. C., Cunningham, J. T., Truillet, C., Tameire, F., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar2036 · Cited by 164

Regulation of ribosomal protein genes: An ordered anarchy

Petibon, C., Ghulam, M. M., Catala, M., & Elela, S. A. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1632 · Cited by 169

Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)

Toren, P., & Zoubeidi, A. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2601 · Cited by 165

ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer

Ye, Q., Cai, W., Zheng, Y., Evers, B. M., & She, Q. (2013) · Oncogene · doi:10.1038/onc.2013.122 · Cited by 168

Onset of differentiation is post-transcriptionally controlled in adult neural stem cells

Baser, A., Skabkin, M. A., Kleber, S., Dang, Y., Balta, G. S. G., Kalamakis, G., Göpferich, M., Ibañez, D. C., Schefzik, R., Lopez, A. S., et al. (2019) · Nature · doi:10.1038/s41586-019-0888-x · Cited by 169

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis

Wang, L., Liu, W., Broussy, S., Han, B., & Fang, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1307860 · Cited by 169

The regulatory potential of upstream open reading frames in eukaryotic gene expression

Wethmar, K. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1245 · Cited by 169

Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives

Ong, P. S., Wang, L. Z., Dai, X., Tseng, S. H., Loo, S. J., & Sethi, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00395 · Cited by 162

High-throughput 5’ UTR engineering for enhanced protein production in non-viral gene therapies

Cao, J., Novoa, E. M., Zhang, Z., Chen, W. C. W., Liu, D., Choi, G. C. G., Wong, A. S. L., Wehrspaun, C., Kellis, M., & Lu, T. K. (2021) · Nature Communications · doi:10.1038/s41467-021-24436-7 · Cited by 159

eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies

Alain, T., Morita, M., Fonseca, B. D., Yanagiya, A., Siddiqui, N., Bhat, M., Zammit, D., Marcus, V., Metrakos, P. P., Voyer, L.-A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2395 · Cited by 165

Molecular Architecture of 4E-BP Translational Inhibitors Bound to eIF4E

Peter, D., Igreja, C., Weber, R., Wohlbold, L., Weiler, C., Ebertsch, L., Weichenrieder, O., & Izaurralde, E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.017 · Cited by 157

Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells

Essig, K., Hu, D., Guimaraes, J. C., Alterauge, D., Edelmann, S. L., Raj, T., Kranich, J., Behrens, G., Heiseke, A. F., Floess, S., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.008 · Cited by 157

Global analysis of LARP1 translation targets reveals tunable and dynamic features of 5′ TOP motifs

Philippe, L., van den Elzen, A. M. G., Watson, M. J., & Thoreen, C. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912864117 · Cited by 161

The Arabidopsis TOR Kinase Specifically Regulates the Expression of Nuclear Genes Coding for Plastidic Ribosomal Proteins and the Phosphorylation of the Cytosolic Ribosomal Protein S6

Dobrenel, T., Mancera-Martínez, E., Forzani, C., Azzopardi, M., Davanture, M., Moreau, M., Schepetilnikov, M. V., Chicher, J., Langella, O., Zivy, M., et al. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01611 · Cited by 160

Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

Zhang, S., Song, X., Cao, D., Xu, Z., Fan, B., Che, L., Hu, J., Chen, B., Dong, M., Pilo, M. G., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.006 · Cited by 152

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice

Albers, J., Rajski, M., Schönenberger, D., Harlander, S., Schraml, P., von Teichman, A., Georgiev, S., Wild, P. J., Moch, H., Krek, W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202231 · Cited by 149

ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer

Hashimoto, S., Furukawa, S., Hashimoto, A., Tsutaho, A., Fukao, A., Sakamura, Y., Parajuli, G., Onodera, Y., Otsuka, Y., Handa, H., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901765116 · Cited by 149

Ribonuclease selection for ribosome profiling

Gerashchenko, M. V., & Gladyshev, V. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw822 · Cited by 156

mTOR kinase inhibitors as potential cancer therapeutic drugs

Sun, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.017 · Cited by 152

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression

Mura, M., Hopkins, T. G., Michael, T., Latip, N. A., Weir, J., Aboagye, E. O., Mauri, F. A., Jameson, C., Sturge, J., Gabra, H., et al. (2014) · Oncogene · doi:10.1038/onc.2014.428 · Cited by 146

Insights into the mechanisms of eukaryotic translation gained with ribosome profiling

Andreev, D. E., O’Connor, P. B. F., Loughran, G., Dmitriev, S. E., Baranov, P. V., & Shatsky, I. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1190 · Cited by 151

Regulation of global and specific mRNA translation by the mTOR signaling pathway

Nandagopal, N., & Roux, P. P. (2014) · Translation · doi:10.4161/21690731.2014.983402 · Cited by 156

Glucose-driven TOR–FIE–PRC2 signalling controls plant development

Ye, R., Wang, M., Du, H., Chhajed, S., Koh, J., Liu, K.-H., Shin, J., Wu, Y., Shi, L., Xu, L., et al. (2022) · Nature · doi:10.1038/s41586-022-05171-5 · Cited by 143

mTORC1 Promotes Denervation-Induced Muscle Atrophy Through a Mechanism Involving the Activation of FoxO and E3 Ubiquitin Ligases

Tang, H., Inoki, K., Lee, M. C., Wright, E., Khuong, A., Khuong, A., Sugiarto, S., Garner, M. S., Paik, J., DePinho, R. A., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004809 · Cited by 145

Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment

Herrmann, D., Conway, J. R. W., Vennin, C., Magenau, A., Hughes, W. E., Morton, J. P., & Timpson, P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu108 · Cited by 144

Translational Control in the Brain in Health and Disease

Sossin, W. S., & Costa-Mattioli, M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032912 · Cited by 138

The Untranslated Regions of mRNAs in Cancer

Schuster, S. L., & Hsieh, A. C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.011 · Cited by 145

Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors

Endo, M., Yamamoto, H., Setsu, N., Kohashi, K., Takahashi, Y., Ishii, T., Iida, K.-I., Matsumoto, Y., Hakozaki, M., Aoki, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1067 · Cited by 137

mTOR: A Cellular Regulator Interface in Health and Disease

Boutouja, F., Stiehm, C. M., & Platta, H. W. (2019) · Cells · doi:10.3390/cells8010018 · Cited by 139

SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy

Roccaro, A. M., Sacco, A., Purschke, W. G., Moschetta, M., Buchner, K., Maasch, C., Zboralski, D., Zöllner, S. K., Vonhoff, S., Mishima, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.042 · Cited by 146

NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase

Kolawole, O. R., & Kashfi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031432 · Cited by 138

A recollection of mTOR signaling in learning and memoryPreprint

Graber, T. E., McCamphill, P. K., & Sossin, W. S. (2013) · Learning & Memory · doi:10.1101/lm.027664.112 · Cited by 143

The director's cut

Gentilella, A., & Thomas, G. (2012) · Nature · doi:10.1038/485050a · Cited by 29

Profiling the translational targets of mTOR signalling

Burgess, D. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3216

Translation initiation: a critical signalling node in cancer

Robert, F., & Pelletier, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903241625 · Cited by 48

P39. Rapamycin and the downstream target of mTOR, ribosomal protein L29 (RPL29), regulate prostate cancer cell growth and bone metastatic potential

Schwarting-Opdenaker, L., Carson, D. D., & Farach‐Carson, M. C. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.081

Abstract A49: Transcription factor upregulation after mTOR inhibition by Torin1 induces growth factor receptor expression

Yang, T. T., Negri, G. L., Kristensen, A. M., & Sorensen, P. H. B. (2017) · Cancer Research · doi:10.1158/1538-7445.transcontrol16-a49